Skip to content

Exploring the Effect of a Polyherbal Formulation for the Treatment of Sandhigatavata (osteoarthritis)

Preclinical and Clinical Evaluation of an Ayurvedic Polyherbal Formulation for the Treatment of Sandhigatavata (osteoarthritis) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086552
Enrollment
60
Registered
2025-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M859- Disorder of bone density and structure, unspecified Health Condition 2: M159- Polyosteoarthritis, unspecified

Interventions

None listed

Sponsors

Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital, Govt. of West Bengal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of both sexes, irrespective of religion , habitat, income status, occupation ,etc. 2.Age between 40 years to 70 years 3.Patients with Primary Osteoarthritis-knee joint{single or both knee} 3.Patients willing to include themselves in the study through informed consent form. 4.kellgren lawrence (Radiologicalscale 2)

Exclusion criteria

Exclusion criteria: 1.Patients having age between 40 - 70 years. 2.Patients suffering with disease like cardiac problem, diabetes mellitus, hepatic disorder, renal disease, malignancies, pregnant mother etc. 3.Patients who are currently participating in any other clinical trial. 4.Patients with skin allergies/ skin skin disease.

Design outcomes

Primary

MeasureTime frame
The primary outcome will be measured based on clinical outcome, Radiological outcome Hematological outcome, Bio-chemical outcome measures, Safety and tolerability outcome measure to determine the effectiveness and safety of the test drug for the treatment of Sandhigatavata (Osteoarthritis)Timepoint: 56 days(8 weeks)

Secondary

MeasureTime frame
The effects of the test drug medication alters the quality of life that will be evaluated after completion of the treatment.Timepoint: 56 days(8 weeks)

Countries

India

Contacts

Public ContactDr Jaypriya Tripura

Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital

atipgaer@gmail.com9874849650

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026